Dutasteride Infusion in Male Androgenetic Alopecia Using a Novel Drug Delivery Technique: MMP

    July 2025 in “ Skin Appendage Disorders ”
    Luciana Gasques, Alice Marques Moreira Lima, Mariana Lima … Marina Barletta
    Studysummary In this study, researchers found that microinfusion of dutasteride using the MMP® technique did not show a statistical difference compared to placebo in clinical assessments for male androgenetic alopecia, though patients reported improvements in the vertex area.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Related research 1

    1. Discovery and Clinical Development of Dutasteride, a Potent Dual 5α-Reductase Inhibitor Current topics in medicinal chemistry · 2006